Please try another search
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Name | Age | Since | Title |
---|---|---|---|
Yat-Gai Au | 50 | 2014 | Founder, Chairman & CEO |
Yi-Chung Chao | 59 | 2020 | Special Advisor & Director |
Yee Wah Hui | 51 | 2021 | Independent Director |
Paul J. Niewiadomski | 52 | 2021 | Independent Director |
Wing-Yan Lo | 62 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review